Decision briefs · index
Decision briefs.
A clinician-grade view per frontier. Each brief is projected from accepted-core findings and validated by the CLI before it lands here. Drafts and needs_revision findings are excluded by filter; the public site cannot show them.
1 of 3 frontiers have a curated decision projection. The rest will appear here automatically when their projections land and validate.
- Anti-amyloid translation available
Lecanemab, donanemab, BACE inhibitor failures, ARIA risk, and the BBB delivery bottleneck for Alzheimer's disease.
- Early-AD biomarker calibration not yet
Calibrating fluid and imaging biomarkers against clinical decline in early Alzheimer's disease.
-
Blood-brain barrier dysfunction and delivery in Alzheimer's, the BBB child frontier.